Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5449]
News [12652]
Articles [175]
Editorials [5]
Conferences [248]
elearning [17]
Sacituzumab goviteca provides clinically meaningful PFS benefit for hormone...
Dr Hope Rugo - University of California San Francisco, San Francisco, USA
Sacituzumab goviteca provides clinically meaningful PFS benefit for hormone receptor HR+/HER2‐ advanced breast cancer patients ( Dr Hope Rugo - University of California San Francisco, San Francisco, USA )
4 Jun 2022
Comment: Sacituzumab govitecan for HR+/HER2‐ advanced breast cancer
Dr Jane Lowe Meisel - Winship Cancer Institute of Emory University, Georgia, USA
Comment: Sacituzumab govitecan for HR+/HER2‐ advanced breast cancer ( Dr Jane Lowe Meisel - Winship Cancer Institute of Emory University, Georgia, USA )
4 Jun 2022
Circulating tumour DNA analysis can help identify the need for adjuvant therapy...
Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia
Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer ( Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia )
4 Jun 2022
UICC announces global coalition to increase access to essential cancer...
Dr Cary Adams - Chief Executive Officer, UICC
UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries ( Dr Cary Adams - Chief Executive Officer, UICC )
4 Jun 2022
Sacituzumab govitecan increases PFS for HR+/HER2- metastatic breast cancer
Dr Hope Rugo - University of California San Francisco, San Francisco, USA
Sacituzumab govitecan increases PFS for HR+/HER2- metastatic breast cancer ( Dr Hope Rugo - University of California San Francisco, San Francisco, USA )
4 Jun 2022
Ibrutinib plus chemoimmunotherapy improved PFS for newly diagnosed MCL
Ibrutinib plus chemoimmunotherapy improved PFS for newly diagnosed MCL ( )
3 Jun 2022
Cancer Services Delivery: Focus on India
Dr Soumitra Datta - Tata Medical Center, Kolkata, India
Cancer Services Delivery: Focus on India ( Dr Soumitra Datta - Tata Medical Center, Kolkata, India )
26 May 2022
Outcomes of clinico-radiologically advanced cancer (cT4b) of buccal mucosa: A...
Dr Prateek Jain - Tata Medical Center, Kolkata, India
Outcomes of clinico-radiologically advanced cancer (cT4b) of buccal mucosa: A retrospective analysis of 104 patients ( Dr Prateek Jain - Tata Medical Center, Kolkata, India )
25 May 2022
Diagnostic performance and survival outcome of SLNB procedure in breast cancer...
Dr Sanjit Kumar Agrawal - Tata Medical Center, Kolkata, India
Diagnostic performance and survival outcome of SLNB procedure in breast cancer patients from a tertiary cancer care centre ( Dr Sanjit Kumar Agrawal - Tata Medical Center, Kolkata, India )
25 May 2022
COMy 2022: Multiple myeloma roundup
Prof Philippe Moreau - University Hospital of Nantes, Nantes, France
COMy 2022: Multiple myeloma roundup ( Prof Philippe Moreau - University Hospital of Nantes, Nantes, France )
24 May 2022
Giving abatacept after checkpoint inhibitors can improve immunotherapy...
Dr Stephen Mok - The University of Texas MD Anderson Cancer Center, Houston, USA
Giving abatacept after checkpoint inhibitors can improve immunotherapy responses in melanoma ( Dr Stephen Mok - The University of Texas MD Anderson Cancer Center, Houston, USA )
19 May 2022
War in Ukraine: Impacts on the Slovakian cancer care system
Dr Darina Sedláková - Slovak League Against Cancer, Bratislava, Slovakia
War in Ukraine: Impacts on the Slovakian cancer care system ( Dr Darina Sedláková - Slovak League Against Cancer, Bratislava, Slovakia )
11 May 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation